Global Life Sciences Research Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Asian Proteomics Services The Asian proteomics services market is driven by technologies and advanced softwares in the industry. The value of the proteomics market was $ 305 million in 2012, and is expected to reach $ 1131 million by 2018, at a CAGR of 24.9%. The report “Asian proteomics services Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Analytical laboratory services, Data analysis and maintenance market. The key players of the market covered in this report are Thermo Fisher Scientific, Sigma- Aldrich Corporation, GE Healthcare, Agilent technologies, and others. |
Upcoming |
|
|
North American Proteomics Services The North American proteomics services market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The report “North American proteomics services Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Analytical laboratory services, Data analysis and maintenance market.The value of the proteomics services market was $ 794 million in 2012, and is expected to reach $ 2 billion by 2018, at a CAGR of 17.2%. The key players of the market covered in this report are Thermo Fisher Scientific, Sigma- Aldrich Corporation, GE Healthcare, Agilent technologies Danaher Corporation and others. |
Upcoming |
|
|
European Proteomics Services The European proteomics services market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 704 billion in 2012, and is expected to reach $ 2 billion by 2018, at a CAGR of 19.5%. The report “European proteomics services Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Analytical laboratory services, Data analysis and maintenance market. The key players of the market covered in this report are Thermo Fisher Scientific, GE Healthcare, Agilent technologies and others. |
Upcoming |
|
|
Europe Polymerase Chain Reaction (PCR) The European polymerase chain reaction market has gained a significant share in the total Polymerase chain reaction market. The market was pegged at $1154 million in 2012 and is estimated to achieve $2708 million by 2018, with a growing CAGR of 16.2%. These reagents can be segmented on the basis of products and various types of preparative reagents, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Asian Polymerase Chain Reaction (PCR) The Asian polymerase chain reaction market has gained a significant share in the total Polymerase chain reaction market. The market was pegged at $1046 million in 2012 and is estimated to achieve $2915 million by 2018, with a growing CAGR of 20.3%. These reagents can be segmented on the basis of products and various types of preparative reagents, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report.” |
Upcoming |
|
|
North America Polymerase Chain Reaction (PCR) The North American polymerase chain reaction market was valued at $1,456 million in 2012 and is estimated to reach $2,724 million by 2018, at a CAGR of 11.3% from 2013 to 2018. The market report provides insights into the market value forecasts, market dynamics such as drivers & restraints, competitive scenario of the market, and the opportunities in the market.In addition, a deep-dive analysis of the top market players has been provided in this report. |
Upcoming |
|
|
North American DNA Microarray The North American geographic segment of the global DNA Microarray market was valued at $423.2 million in 2013 and is the largest regional contributor to the global genomics market. The North American region is expected to witness a relatively large number of innovations in genomics research in terms of technology and expansion of application areas to improve human health. |
Upcoming |
|
|
European DNA Microarray The market value was pegged at $337.5 million in 2013 and is expected to grow at a CAGR of 16.2% from 2014 to 2019.The market can be segmented on the basis of types and applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Asia-Pacific DNA Microarray The Asn DNA microarray market has gained a significant share in the total DNA microarray market. The market was pegged at $274 million in 2012 and is estimated to achieve $791 million by 2018, with a growing CAGR of 21.5%. The market can be segmented on the basis of types and applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
North America In Situ Hybridization The North American hybridization market has gained a significant share in the total hybridization market. The market was pegged at $277 million in 2012 and is estimated to achieve $528 million by 2018, with a growing CAGR of 11.2%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Asia-Pacific In Situ Hybridization The Asian hybridization market has gained a significant share in the total hybridization market. The market was pegged at $200 million in 2012 and is estimated to achieve $403 million by 2018, with a growing CAGR of 12.4%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Global In Situ Hybridization In-situ hybridization (ISH) is a technique that helps to identify the exact location of a specific segment of nucleic acid that is a DNA or RNA, in a cell or tissue (in-situ). The most commonly used in-situ hybridization is DNA-FISH. |
Jul 2015 |
|
|
Europe In Situ Hybridization The European hybridization market has gained a significant share in the total hybridization market. The market was pegged at $221 million in 2012 and is estimated to achieve $417 million by 2018, with a growing CAGR of 11%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
North America Isothermal Nucleic Acid Amplification The North American isothermal nucleic acid amplification market has gained a significant share in the isothermal nucleic acid amplification market. The market was pegged at $240 million in 2012 and is estimated to achieve $590 million by 2018, with a growing CAGR of 15.9%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Asian Isothermal Nucleic Acid Amplification The Asian isothermal nucleic acid amplification market has gained a significant share in the isothermal nucleic acid amplification market. The market was pegged at $173 million in 2012 and is estimated to achieve $450 million by 2018, with a growing CAGR of 17.1%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Isothermal Nucleic Acid Amplification Isothermal Nucleic Acid Amplification and DNA Sequencing, DNA... |
Upcoming |
|
|
Europe Isothermal Nucleic Acid Amplification The European isothermal nucleic acid amplification market has gained a significant share in the isothermal nucleic acid amplification market. The market was pegged at $192 million in 2012 and is estimated to achieve $466 million by 2018, with a growing CAGR of 15.7%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
Life Sciences Research
